36 related articles for article (PubMed ID: 18285702)
1. Protein expression of cell cycle regulator, p27Kip1, correlates with histopathological grade of non-Hodgkin's lymphoma.
Kudoh S; Kumaravel TS; Kuramavel B; Eguchi M; Asaoku H; Dohy H; Fujiwara M; Sasaki N; Tanaka K; Kamada N
Jpn J Cancer Res; 1999 Nov; 90(11):1262-9. PubMed ID: 10622539
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of c-Jun activation domain-binding protein-1 in cancer: A systematic review and meta-analysis.
Shi D; Mu S; Hu B; Zhang S; Liu J; Zhang Z; Shao Z
J Cell Mol Med; 2021 Mar; 25(6):2750-2763. PubMed ID: 33550701
[TBL] [Abstract][Full Text] [Related]
3. JAB1-STAT3 activation loop is associated with recurrence following 5-fluorouracil-based adjuvant chemotherapy in human colorectal cancer.
Kugimiya N; Nishimoto A; Hosoyama T; Ueno K; Takemoto Y; Harada E; Enoki T; Hamano K
Oncol Lett; 2017 Nov; 14(5):6203-6209. PubMed ID: 29113268
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of early mitotic inhibitor-1 predicts a poor prognosis in esophageal squamous cell carcinoma patients.
Guan C; Zhang J; Zhang J; Shi H; Ni R
Oncol Lett; 2016 Jul; 12(1):114-120. PubMed ID: 27347110
[TBL] [Abstract][Full Text] [Related]
5. TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway.
Chen J; Gu J; Feng J; Liu Y; Xue Q; Ni T; Wang Z; Jia L; Mao G; Ji L
Tumour Biol; 2016 Mar; 37(3):3851-61. PubMed ID: 26476534
[TBL] [Abstract][Full Text] [Related]
6. Upregulated expression of polycomb protein Ring1 contributes to poor prognosis and accelerated proliferation in human hepatocellular carcinoma.
Xiong Y; Hu B; Wei L; Jiang D; Zhu M
Tumour Biol; 2015 Dec; 36(12):9579-88. PubMed ID: 26141041
[TBL] [Abstract][Full Text] [Related]
7. Polycomb group oncogene RING1 is over-expressed in non-small cell lung cancer.
Zhou Y; Wan C; Liu Y; Lv L; Chen B; Ni R; Huang Y; Li Y; Zheng X; Yang D; Mao G; Xue Q
Pathol Oncol Res; 2014 Jul; 20(3):549-56. PubMed ID: 24414991
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic role of c-Myb as a novel cell cycle protein in esophageal squamous cell carcinoma.
Lu H; Wang Y; Huang Y; Shi H; Xue Q; Yang S; He S; Wang H
Clin Transl Oncol; 2013 Oct; 15(10):796-801. PubMed ID: 23658056
[TBL] [Abstract][Full Text] [Related]
9. JAB1/CSN5: a new player in cell cycle control and cancer.
Shackleford TJ; Claret FX
Cell Div; 2010 Oct; 5():26. PubMed ID: 20955608
[TBL] [Abstract][Full Text] [Related]
10. Significance of Jab1 expression in human esophageal squamous cell carcinoma.
Wang F; Wang Y; Yu X; Yang D; Wang Z; Lu C; Yuan Z; Xiao M; Shen A
J Clin Gastroenterol; 2009 Jul; 43(6):520-6. PubMed ID: 19349901
[TBL] [Abstract][Full Text] [Related]
11. HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27Kip1 via multiple signaling pathways.
Le XF; Pruefer F; Bast RC
Cell Cycle; 2005 Jan; 4(1):87-95. PubMed ID: 15611642
[TBL] [Abstract][Full Text] [Related]
12. Jab1 as a mediator of nuclear export and cytoplasmic degradation of p53.
Lee EW; Oh W; Song J
Mol Cells; 2006 Oct; 22(2):133-40. PubMed ID: 17085963
[TBL] [Abstract][Full Text] [Related]
13. Jun activation domain-binding protein 1 negatively regulate p27 kip1 in non-Hodgkin's lymphomas.
Wang Y; Fei M; Cheng C; Zhang D; Lu J; He S; Zhao Y; Wang Y; Shen A
Cancer Biol Ther; 2008 Mar; 7(3):460-7. PubMed ID: 18285702
[TBL] [Abstract][Full Text] [Related]
14. Expression of Jun activation domain-binding protein 1 and Ser10 phosphorylated p27 protein in human epithelial ovarian carcinoma.
Wang Y; Wang Y; Cheng C; Ji Y; Zhao Y; Zou L; Shen A
J Cancer Res Clin Oncol; 2009 Jul; 135(7):951-9. PubMed ID: 19139918
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas.
Dong Y; Sui L; Watanabe Y; Yamaguchi F; Hatano N; Tokuda M
Clin Cancer Res; 2005 Jan; 11(1):259-66. PubMed ID: 15671554
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
